article thumbnail

Episode 176: Antiracism in Medicine Series – Episode 8 – Towards Justice and Race Conscious Medicine

The Clinical Problem Solvers

The answer to this question may not be easily answered and may not always be found in the clinical setting. The use of race is based on a false/biological concept of race AND many studies show that this can harm patients ( i.e. clinical resources are withheld based on results of algorithm).

article thumbnail

Agitation Podcast Series Episode 5: Management of the child with mental health problems who is boarded in the ED

PEMBlog

This episode is a co-production of the Emergency Medical Services for Children Innovation and Improvement Center whose mission is to minimize morbidity and mortality of acutely ill and injured children across the emergency continuum. Children’s Mental Health Emergency Department Visits: 2007-2016. Government. Pediatrics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Exploring the Use of Intranasal Dexmedetomidine for Anxiolysis and Minimal Sedation

PEMBlog

Let’s take a closer look at what makes this medication so useful, particularly when given intranasally. Dexmedetomidine, often known by its brand name Precedex, is a fascinating medication. Whether you’re dealing with imaging studies or laceration repairs, this medication offers a reliable way to keep patients calm and comfortable.

article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. This parallels another process, which is the medicalization of human experiences, especially those relating to childbirth and pregnancy.

article thumbnail

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

GeriPal

When we have a medication with up front harms and downstream benefits, it’s critical that we consider the time to benefit, or how long it will take an individual to benefit from a test or treatment. And really, the more important question is how quickly they would benefit from starting these medications. See screenshot below.

Clinic 67
article thumbnail

The Future of Geriatrics: A Podcast with Jerry Gurwitz, Ryan Chippendale, and Mike Harper

GeriPal

Alex: Today we’re delighted to welcome Jerry Gurwitz, who is a geriatrician and professor of medicine at the UMass Chan Medical School. I talked about lack of prestige and respect, and I talked about how healthcare system leaders and medical school deans don’t always seem to value the field of geriatrics.

article thumbnail

Palliative Care Pioneer: Susan Block

GeriPal

He’s assistant professor of medicine at UCSF, and he’s one of my former research mentees, and he’s very interested in medical ethics and decision making in the ICU. Myself personally, I was in PCEP at Harvard, I think like 2007 or something with Rachelle Bernacki and a bunch of other great people. Susan: Beautiful.

Illness 109